Back
Can-Fite BioPharma Ltd. 10K Form
Sell
10
CANF
Can-Fite BioPharma Ltd.
Last Price:
$3.12
Seasonality Move:
-13.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CANF News And Ratings
See the #1 stock for the next 7 days that we like better than CANF
CANF Financial Statistics
Sales & Book Value
| Annual Sales: | $408.2K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0.65 |
Profitability
| EPS (TTM): | -12.44980 |
|---|---|
| Net Income (TTM): | $-9.9M |
| Gross Margin: | $384K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Can-Fite BioPharma Ltd. Earnings Forecast
Key Can-Fite BioPharma Ltd. Financial Ratios
-
The Gross Profit Margin over the past 21 years for CANF is 94.07%.
-
The Selling, General & Administrative Expenses for CANF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 1,652.65% of Revenue.
-
The Net Earning history of CANF is -2,426.75% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 12 years.
Can-Fite BioPharma Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CANF |
| CUSIP: | 13471N |
| Website: | canfite.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CANF Technical Analysis vs Fundamental Analysis
Sell
10
Can-Fite BioPharma Ltd. (CANF)
is a Sell
Is Can-Fite BioPharma Ltd. a Buy or a Sell?
-
Can-Fite BioPharma Ltd. stock is rated a SellThe current Can-Fite BioPharma Ltd. [CANF] share price is $3.07. The Score for CANF is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.